About the Retrovirus Session
Retroviruses are a class of viruses that use a unique replication process involving the conversion of their RNA genome into DNA using an enzyme called reverse transcriptase. The viral DNA is subsequently merged into the genetic material of the host cell. HIV (Human Immunodeficiency Virus) is a notable example of a retrovirus, exemplifying this particular class of viruses. These viruses are notable for their ability to cause chronic infections due to their integration into the host's genetic material. HIV, for instance, attacks the immune system, leading to acquired immunodeficiency syndrome (AIDS) if left untreated. Retroviruses are communicable diseases, primarily spreading through direct contact with bodily fluids, such as blood, semen, and breast milk, or from mother to child during childbirth or breastfeeding. Preventive measures include safe sex practices, needle exchange programs, and antiretroviral medications for those with HIV. Understanding the unique replication mechanism of retroviruses is crucial in developing effective treatments and preventive strategies. Ongoing research in this field contributes to advancements in antiretroviral therapies and vaccine development, aiming to control the spread of retroviral infections and manage their impact on global health.
Topics Covered in Retrovirus
Reverse transcription and viral integration
HIV transmission and prevention strategies
Antiretroviral therapy and treatment adherence
Mother-to-child transmission prevention
Retroviral vaccine research and development
HIV testing, diagnosis and linkage to care
Featured Speakers — Retrovirus 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Retrovirus Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at IPHC 2027
Why Attend the Retrovirus Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Retrovirus work, reviewed by the scientific committee.
Network Globally
Meet public health researchers, educators, and policy leaders from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Retrovirus research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IPHC 2027 for the Retrovirus track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Retrovirus Conference 2027 — FAQs
What is the Retrovirus track at IPHC 2027?
The Retrovirus track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Retrovirus. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Retrovirus sessions?
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Retrovirus are all welcome — whether presenting or attending.
Can I present my research in the Retrovirus track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Retrovirus sessions?
Yes. IPHC 2027 is a hybrid conference — attend the Retrovirus track in person in Singapore or join live online, with on-demand access afterward.
Join the IPHC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
